Drug-Induced Immune Hemolytic Anemia Introduction

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 181 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Immune Hemolytic Anemias. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Immune Hemolytic Anemias (online CE course)
Drug-Induced Immune Hemolytic Anemia Introduction

Drug-induced immune hemolytic anemia is a rare category of autoimmune hemolytic anemias. Antibodies produced in response to a medication, or its metabolite, are the cause of hemolytic anemia. The drug may cause a positive DAT, which may or may not be associated with immune hemolysis. Patients may present with similar serological and laboratory findings as the other types of autoimmune hemolytic anemias and may be difficult to differentiate. Accurate medication history is beneficial in the resolution of the serologic presentation.